Osteopetrosis

Osteopetrosis is a rare bone disorder where the bones become abnormally dense and hard due to defective bone breakdown. This condition affects the skeletal system, leading to bones that are more brittle and prone to fractures despite their increased density. The main problem arises because the cells responsible for bone resorption, called osteoclasts, do not work properly. As a result, old bone is not removed efficiently, causing bones to become overly thick and sometimes deform. This can lead to complications such as bone pain, frequent fractures, and problems with bone marrow function, which affects blood cell production. Additionally, the increased bone density can compress nerves, causing symptoms like vision or hearing loss. Overall, osteopetrosis impacts both bone strength and the body's ability to produce healthy blood cells.

Osteopetrosis is a group of rare genetic disorders characterized by defective osteoclast-mediated bone resorption, resulting in abnormally dense but brittle bones. The core pathology involves mutations affecting osteoclast function or differentiation, commonly in genes such as TCIRG1, CLCN7, or OSTM1, leading to impaired acidification and bone matrix degradation. This failure to resorb bone causes excessive bone mass with disorganized architecture, increasing fracture risk despite increased radiographic density. Clinically, patients present with bone fragility, anemia due to bone marrow space obliteration, cranial nerve compression symptoms, and sometimes hypocalcemia. The disease manifests in various forms, including autosomal recessive infantile malignant osteopetrosis and autosomal dominant adult benign osteopetrosis. The condition is significant due to its impact on skeletal integrity and hematopoiesis, often requiring early diagnosis and management to prevent severe complications.